Postmenopausal osteoporosis

MD Walker, E Shane - New England Journal of Medicine, 2023 - Mass Medical Soc
Key Clinical Points Postmenopausal Osteoporosis Fragility fractures are very common
among postmenopausal women and are associated with increased morbidity, mortality, and …

Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis …

C Ayers, D Kansagara, B Lazur, R Fu… - Annals of internal …, 2023 - acpjournals.org
An update is available for this article. Background: The prevalence of osteoporosis is
increasing in the United States. Purpose: To evaluate low bone mass and osteoporosis …

Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians

A Qaseem, LA Hicks… - Annals of internal …, 2023 - acpjournals.org
An update is available for this article. Description: This guideline updates the 2017 American
College of Physicians (ACP) recommendations on pharmacologic treatment of primary …

Reporting of observational studies explicitly aiming to emulate randomized trials: a systematic review

HJ Hansford, AG Cashin, MD Jones… - JAMA Network …, 2023 - jamanetwork.com
Importance Observational (nonexperimental) studies that aim to emulate a randomized trial
(ie, the target trial) are increasingly informing medical and policy decision-making, but it is …

Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated …

H Tao, W Li, W Zhang, C Yang, C Zhang, X Liang… - Pharmacological …, 2021 - Elsevier
Osteoporosis (OP) is characterized by decreased trabecular bone volume and
microarchitectural deterioration in the medullary cavity. Urolithin A (UA) is a biologically …

Stop** renin-angiotensin system inhibitors in patients with advanced CKD and risk of adverse outcomes: a nationwide study

EL Fu, M Evans, CM Clase, LA Tomlinson… - Journal of the …, 2021 - journals.lww.com
Background It is unknown whether stop** renin-angiotensin system (RAS) inhibitor
therapy in patients with advanced CKD affects outcomes. Methods We studied patients …

Target trial emulation to improve causal inference from observational data: what, why, and how?

EL Fu - Journal of the American Society of Nephrology, 2023 - journals.lww.com
Target trial emulation has drastically improved the quality of observational studies
investigating the effects of interventions. Its ability to prevent avoidable biases that have …

Denosumab discontinuation and the rebound phenomenon: a narrative review

AD Anastasilakis, P Makras, MP Yavropoulou… - Journal of clinical …, 2021 - mdpi.com
Denosumab is a potent antiresorptive agent that substantially increases bone mineral
density and reduces fracture rates at all skeletal sites for as long as it is administered …

[HTML][HTML] COVID-19 and the endocrine system: a comprehensive review on the theme

G Lisco, A De Tullio, A Stragapede… - Journal of clinical …, 2021 - mdpi.com
Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …